Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of Peri-Operative Modified Folfirinox in Localized Pancreatic Cancer

NCT02047474 is registered in ClinicalTrials.gov with Yale University as lead sponsor.

NCT NCT02047474
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02047474 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of Peri-Operative Modified Folfirinox in Localized Pancreatic Cancer
Lead sponsor
Yale University
Phase
Phase 2
Overall status
Completed
Start date
March 25, 2014
Completion date
January 14, 2024
Enrollment
46 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

acinar cell adenocarcinoma of the pancreas, duct cell adenocarcinoma of the pancreas, stage i pancreatic cancer, stage iia pancreatic cancer, stage iib pancreatic cancer